White Paper · Cannabis & Hemp · Missouri

Missouri’s Intoxicating Cannabinoid Control Act: Which Products Change on November 12, 2026

HB 2641 treats hemp-derived cannabinoid products as marijuana under Article XIV, with two effective-date tracks. Four product categories move on November 12. A second group is tied to the federal hemp schedule, which Congress delayed in September.

By Lincoln Square Law · 11-minute read

What Missouri businesses need to know first

Missouri enacted House Bill 2641, the Intoxicating Cannabinoid Control Act, as new section 195.900 of the Revised Statutes of Missouri. The Governor signed it on April 23, 2026, and it takes effect on November 12, 2026 (HB 2641, sec. B). Under the Act, hemp-derived cannabinoid products are marijuana. Their cultivation, manufacture, testing, transport, and retail sale may occur only through facilities licensed under Article XIV of the Missouri Constitution (RSMo 195.900.3, .7).

The Act does not move every product on the same day. Four categories are covered on November 12, including synthetic and synthesized cannabinoids, smokable raw flower containing any THCA, and certain solid edibles with hemp-derived delta-9 THC. All other hemp-derived cannabinoid products follow a second rule that depends on whether Congress delayed the federal hemp restrictions. Congress did delay most of them, to December 11, 2026, in a law signed September 2 (see our federal hemp transition briefing). Sorting products into the right track is the first job.

How the Act defines hemp and hemp-derived cannabinoid products

The Act defines hemp as the plant Cannabis sativa L. and its derivatives with a total tetrahydrocannabinol concentration, including tetrahydrocannabinolic acid (THCA), of not more than 0.3 percent on a dry-weight basis (RSMo 195.900.2(3)). THCA is the acid form of THC that converts to delta-9 THC when heated, so a total-THC test can reach flower that a delta-9-only test would pass (7 C.F.R. 990.1).

The hemp definition then excludes four groups, in language that closely follows the new federal definition in section 781 of Public Law 119-37. Excluded are viable seeds above the limit. Also excluded are intermediate products with cannabinoids the plant cannot produce, with plant-producible cannabinoids synthesized or manufactured outside the plant, or with more than 0.3 percent combined total THC and similar-effect cannabinoids. Intermediate products sold as final products or to consumers are excluded. Final products are excluded if they contain either kind of synthesized cannabinoid or more than 0.4 milligrams combined total per container of THC and similar-effect cannabinoids (RSMo 195.900.2(3)(a)-(d)). The similar-effect cannabinoids are those identified by the U.S. Secretary of Health and Human Services.

A hemp-derived cannabinoid product is any intermediate or final product derived from hemp, other than industrial hemp, that contains cannabinoids in any form, excluding certain FDA-approved drugs (RSMo 195.900.2(4)). Industrial hemp covers hemp grown for stalks, seeds and grain, microgreens, research, and viable seed for those uses (RSMo 195.900.2(5)). The Act also defines a “transaction” as the sale of a single unit, including one unit within a multiunit package (RSMo 195.900.2(8)). That definition matters for penalties.

Hemp-derived cannabinoid products are treated as marijuana

The central rule is simple to state. All hemp-derived cannabinoid products are marijuana and are subject to the Department of Health and Senior Services and the Attorney General under Article XIV. The Act directs enforcement so that no such product is cultivated, manufactured, tested, transported, or sold in Missouri outside a licensed comprehensive facility, medical facility, marijuana testing facility, or marijuana microbusiness facility (RSMo 195.900.3, .7).

The Act also says what it does not reach. Hemp and industrial hemp are not marijuana and are not subject to Article XIV or the Act. Products outside the definition of hemp-derived cannabinoid products are not regulated by it, and the Act is not to be construed to conflict with or preempt the 2018 Farm Bill (RSMo 195.900.5). Nothing in the Act prohibits interstate commerce in hemp or its transport through Missouri (RSMo 195.900.6).

The first track: four categories covered on November 12

Subsection 11(1)(a) makes the Act effective on November 12, 2026 for hemp-derived cannabinoid products that do any of the following:

• contain cannabinoids that are not capable of being naturally produced by a Cannabis sativa L. plant
• contain plant-producible cannabinoids that were synthesized or manufactured outside the plant
• are sold, distributed, or marketed to consumers as smokable or vapeable raw plant material, flower, or bud and contain any amount of THCA
• are sold, distributed, or marketed to consumers as a solid candy, gummy, chewable product, tablet, capsule, oil, baked good, or other solid edible and contain hemp-derived delta-9 THC above the naturally occurring concentration in the source plant material

These categories do not wait for federal law. Two of them go further than the federal November 12 phase. Federal law reaches only cannabinoids the plant cannot produce until December 11, while Missouri also reaches synthesized plant-producible cannabinoids on November 12. The THCA flower category turns on “any amount” of THCA, not the 0.3 percent total-THC line. The edible category turns on delta-9 above natural concentrations, not the 0.4-milligram container limit. A product that would pass the federal test after December 11 can still fall into one of these Missouri categories.

The second track: products tied to the federal schedule

All other hemp-derived cannabinoid products fall under subsection 11(2). For them, the Act takes effect November 12, 2026, “except that if Congress delays the effective date of federal hemp restrictions” under 7 U.S.C. 1639o on or before that date, the Act applies to those products “only during any period in which such federal restrictions prohibit such products.” Even then, those products may not be sold, distributed, or marketed to anyone under 21 (RSMo 195.900.11(2)).

Congress acted before November 12. Section 2019 of division B of Public Law 119-103, signed September 2, 2026, provides that until December 11, 2026 the section 781 amendments apply only to products containing cannabinoids the plant cannot naturally produce. That appears to be the kind of delay subsection 11(2) contemplates. On that reading, second-track products are subject to the under-21 rule from November 12. The Act’s other provisions would apply to them only when, and to the extent that, the federal definition excludes them from hemp, which under current law begins December 11.

That reading leaves real questions. Subsection 11(2) does not say how it treats a product that federal law never prohibits, such as a final product at or below the 0.4-milligram limit with no synthesized cannabinoids. Subsection 7 says all hemp-derived cannabinoid products are marijuana, while subsection 11(2) limits when the Act applies to some of them. The Act also lists “oil” among solid edibles and does not mention beverages by name. These are matters of statutory interpretation that a regulator or court may resolve. As of this writing, we have not located Department of Health and Senior Services guidance that answers them.

Penalties and who enforces

A person or entity that violates section 195.900 is subject to a fine of $5,000 per transaction and is guilty of a class D felony (RSMo 195.900.10). Because a transaction is the sale of a single unit, exposure scales with the number of units sold rather than the number of SKUs.

Enforcement authority is shared. The Attorney General, the Department of Health and Senior Services, the Department of Public Safety, its Division of Alcohol and Tobacco Control, the Missouri State Highway Patrol, and any other agency the Attorney General deems necessary may enforce the Act. The Attorney General has primary jurisdiction and may coordinate with prosecutors and local governments and use the department’s reference laboratory (RSMo 195.900.9).

The “dispensary” name restriction

A business that sells products containing cannabidiol, hemp, marijuana, or cannabinoids, hemp-derived cannabinoid products, or related paraphernalia may not use “dispensary” or any word of similar import in its name unless it is a licensed comprehensive, medical, or microbusiness dispensary facility under Article XIV (RSMo 195.900.8). That reaches CBD-only retailers as well as hemp shops. Review the legal name, any fictitious name registration, signage, domain names, social profiles, map listings, and marketplace storefronts, and allow lead time for changes that require filings.

Two provisions licensed operators should not miss

HB 2641 also enacted two privacy provisions for the licensed system. Section 195.800 bars state agencies and their employees from disclosing lists of medical marijuana card holders, or information about them, to the federal government or unauthorized third parties absent a court order or subpoena, and a knowing violation is a class E felony. Section 195.819 generally prohibits marijuana dispensaries from keeping records of consumers’ identifying information unless the consumer agrees in writing and is not refused service for declining, with a $500 fine per occurrence. Dispensaries should review loyalty programs, point-of-sale data fields, and customer relationship management systems against section 195.819 before November 12.

What licensed facilities should check before taking former hemp products

A licensed facility cannot convert an unlicensed product by relabeling it. Under subsection 3, every step in the chain, from cultivation to retail sale, must be performed by an entity licensed by the department. Before onboarding a former hemp brand or supplier, confirm which licensed facility will manufacture the product, how it will enter the state tracking system, what testing applies, and whether packaging and labeling meet the department’s marijuana rules. Contracts with former hemp suppliers should allocate the cost of failed testing, unusable inventory, and regulatory holds.

What this means for Illinois businesses selling into Missouri

Illinois’s own Hemp Act also takes effect November 12, 2026, and the Illinois Department of Revenue has said Illinois will enforce it on that date. An Illinois manufacturer or distributor shipping into Missouri therefore faces three analyses on overlapping dates: Illinois, Missouri, and federal. A product lawful to make in Illinois is not lawful to sell to a Missouri retailer simply because Illinois permits it. Missouri’s November 12 categories, and its exclusion of hemp-derived cannabinoid products from ordinary retail, apply at the point of Missouri sale. Missouri’s interstate-commerce clause protects hemp in transit, but it does not authorize unlicensed sale of hemp-derived cannabinoid products inside Missouri.

Inventory decisions before November 12

Classify each Missouri SKU into the first track, the second track, or outside the Act. For first-track products sold outside the licensed system, plan removal from Missouri channels before November 12. The Act contains no sell-through period that we have found. For second-track products, put an under-21 control in place for November 12 and calendar December 11 for a second review. Record the facts behind each classification, including the cannabinoid source, the THCA result for flower, the delta-9 source and concentration for edibles, and the per-container total for final products.

Before relying on any of these dates, check whether a court has entered an order affecting the Act. As of this writing, we have not located any order that changes its November 12 effective date.

What to ask counsel about your Missouri SKUs

Which of our Missouri SKUs fall in subsection 11(1)(a)? How should a product that federal law will not prohibit be treated under subsection 11(2)? Does our business name or any listing use “dispensary”? What units are in Missouri channels now, and what is our per-transaction exposure if they remain after November 12? If we are a licensed facility, do our customer records comply with section 195.819?